CTAP
CTAP is a potent, highly selective, and blood–brain barrier penetrant antagonist of μ opioid receptor with an IC50 of 3.5 nM. It displays over 1200-fold selectivity over δ opioid and somatostatin receptors. It exhibits anti-dyskinetic potential and can be used for the study of L-DOPA-induced dyskinesia (LID) and opiate overdose or addiction.
| Catalog Number | E7162 |
| Molecular Formula | C8H11N3O3S |
| CAS# | 103429-32-9 |
| Inchi | InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1 |
| Inchi Key | JTEGQNOMFQHVDC-NKWVEPMBSA-N |
| SMILES | C1C(OC(S1)CO)N2C=CC(=NC2=O)N |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/ctap.html |
| Additional Information | https://file.selleck.cn/downloads/struct/E7162-CTAP-chemical-structure.png |